S&P 500   2,994.40 (-0.12%)
DOW   26,963.59 (-0.23%)
QQQ   193.04 (-0.20%)
AAPL   235.80 (+0.63%)
FB   189.62 (-0.03%)
MSFT   138.97 (-0.36%)
AMZN   1,775.28 (-0.84%)
NVDA   193.21 (+0.32%)
MU   44.37 (-2.36%)
BABA   172.59 (-2.07%)
TSLA   259.78 (-1.01%)
F   9.21 (+1.32%)
ACB   3.78 (-0.53%)
PRI   124.26 (+0.24%)
NFLX   282.65 (-3.65%)
BAC   30.21 (+0.47%)
GILD   64.92 (-0.37%)
DIS   132.52 (-0.26%)
S&P 500   2,994.40 (-0.12%)
DOW   26,963.59 (-0.23%)
QQQ   193.04 (-0.20%)
AAPL   235.80 (+0.63%)
FB   189.62 (-0.03%)
MSFT   138.97 (-0.36%)
AMZN   1,775.28 (-0.84%)
NVDA   193.21 (+0.32%)
MU   44.37 (-2.36%)
BABA   172.59 (-2.07%)
TSLA   259.78 (-1.01%)
F   9.21 (+1.32%)
ACB   3.78 (-0.53%)
PRI   124.26 (+0.24%)
NFLX   282.65 (-3.65%)
BAC   30.21 (+0.47%)
GILD   64.92 (-0.37%)
DIS   132.52 (-0.26%)
Log in

Iterum Therapeutics Price Target & Analyst Ratings (NASDAQ:ITRM)

$3.98
-0.04 (-1.00 %)
(As of 10/18/2019 10:21 AM ET)
Today's Range
$3.98
Now: $3.98
$4.05
50-Day Range
$3.93
MA: $5.81
$6.96
52-Week Range
$3.80
Now: $3.98
$9.30
Volume2,519 shs
Average Volume18,353 shs
Market Capitalization$55.56 million
P/E RatioN/A
Dividend YieldN/A
Beta2.01

Analyst Ratings

Iterum Therapeutics (NASDAQ:ITRM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Iterum Therapeutics in the last 12 months. Their average twelve-month price target is $18.00, suggesting that the stock has a possible upside of 352.28%. The high price target for ITRM is $20.00 and the low price target for ITRM is $17.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $18.00$18.00$18.00$20.75
Price Target Upside: 352.28% upside164.71% upside172.73% upside170.53% upside

Iterum Therapeutics (NASDAQ:ITRM) Consensus Price Target History

Iterum Therapeutics (NASDAQ:ITRM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/15/2019HC WainwrightReiterated RatingBuy$17.00Medium
5/15/2019Royal Bank of CanadaLower Price TargetOutperform$17.00Low
3/25/2019Needham & Company LLCReiterated RatingBuy$20.00Low
10/22/2018GabelliReiterated RatingBuyLow
6/19/2018Leerink SwannInitiated CoverageOutperform$18.00High
6/19/2018GuggenheimInitiated CoverageBuy$21.00High
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Featured Article: What is a Roth IRA?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel